S. Sonda

发表

Discovery and preclinical profile of teneligliptin (3-[(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl]thiazolidine): a highly potent, selective, long-lasting and orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.

H. Utsumi, S. Kiuchi, Yoshinobu Nakamaru, 2012, Bioorganic & medicinal chemistry.

Cholesterol Esterification by Host and Parasite Is Essential for Optimal Proliferation of Toxoplasma gondii *

Robert V Farese, L. Ting, J. Ernst, 2001, The Journal of Biological Chemistry.

Design and synthesis of orally active benzamide derivatives as potent serotonin 4 receptor agonist.

N. Sato, T. Murozono, K. Haga, 2003, Bioorganic & medicinal chemistry.

Synthesis and pharmacological evaluation of carboxamide derivatives as selective serotoninergic 5-HT4 receptor agonists

N. Sato, K. Itoh, K. Haga, 1999 .

1,5-Benzodioxepin derivatives as a novel class of muscarinic M3 receptor antagonists.

H. Sakashita, M. Fujio, S. Sonda, 2007, Bioorganic & medicinal chemistry letters.

Fused bicyclic heteroarylpiperazine-substituted L-prolylthiazolidines as highly potent DPP-4 inhibitors lacking the electrophilic nitrile group.

Hiroshi Sakashita, Yoshiharu Hayashi, Ikuko Miyaguchi, 2012, Bioorganic & medicinal chemistry.

Synthesis and pharmacological properties of novel benzamide derivatives acting as ligands to the 5-hydroxytryptamine 4 (5-HT4) receptor

N. Sato, K. Itoh, M. Fujimura, 1999 .

Partially hydroxy depleted calixarene-like compounds

Koichi Tanaka, A. Tsuge, M. Tashiro, 1991 .

Synthesis and pharmacological evaluation of benzamide derivatives as selective 5-HT(4) receptor agonists.

N. Sato, Toshio Kawahara, S. Sonda, 2005, Bioorganic & Medicinal Chemistry.

Synthesis and pharmacological evaluation of benzamide derivatives as selective 5-HT4 receptor agonists

N. Sato, Toshio Kawahara, S. Sonda, 2005 .

Discovery and preclinical profile of teneligliptin (3-[(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl]thiazolidine): a highly potent, selective, long-lasting and orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.

H. Utsumi, S. Kiuchi, Yoshinobu Nakamaru, 2012, Bioorganic & medicinal chemistry.